Basil S. Lewis
Impact in
- Internal Medicine top 0.02%
- Venous Thromboembolism Diagnosis and Management
- Cardiology and Cardiovascular Medicine top 0.02%
- Atrial Fibrillation Management and Outcomes
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac Arrhythmias and Treatments
- Acute Myocardial Infarction Research
Papers in
-
- Cardiovascular Function and Risk Factors 47
- Atrial Fibrillation Management and Outcomes 37
- Antiplatelet Therapy and Cardiovascular Diseases 36
- Heart Failure Treatment and Management 33
- Acute Myocardial Infarction Research 33
- Cardiac Arrhythmias and Treatments 27
- Surgery 83
- Coronary Interventions and Diagnostics 36
- Co-authors
- Salim Yusuf (12 shared papers)Michael D. Ezekowitz (3 shared papers)Harald Darius (3 shared papers)Robert P. Giugliano (17 shared papers)Lars Wallentin (24 shared papers)Denis Xavier (4 shared papers)Campbell Joyner (2 shared papers)Rafael Díaz (5 shared papers)
- Journals
- The American Journal of Cardiology (27 papers)American Heart Journal (22 papers)Cardiology (20 papers)Circulation (18 papers)European Heart Journal - Cardiovascular Pharmacotherapy (16 papers)
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
Basil S. Lewis
266 papers receiving 26.9k citations
Basil S. Lewis's Hit Papers
Peers
Comparison fields: 5 of 163
- Internal Medicine 6.9k
- Cardiology and Cardiovascular Medicine 20.1k
- Surgery 8.6k
- Endocrinology, Diabetes and Metabolism 2.9k
- Radiology, Nuclear Medicine and Imaging 2.5k
Countries citing papers authored by Basil S. Lewis
This map shows the geographic impact of Basil S. Lewis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Basil S. Lewis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Basil S. Lewis more than expected).
Fields of papers citing papers by Basil S. Lewis
This network shows the impact of papers produced by Basil S. Lewis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Basil S. Lewis. The network helps show where Basil S. Lewis may publish in the future.
Co-authors
The 25 scholars most cited alongside Basil S. Lewis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 278 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dabigatran versus Warfarin in Patients with Atrial Fibrillation Hit paper breakdown → | 2009 | 7989 |
| 2 | Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials Hit paper breakdown → | 2013 | 3295 |
| 3 | Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes Hit paper breakdown → | 2015 | 2870 |
| 4 | Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Hit paper breakdown → | 2001 | 1957 |
| 5 | Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial Hit paper breakdown → | 2011 | 1374 |
| 6 | Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial Hit paper breakdown → | 2014 | 545 |
| 7 | 2003 | 492 | |
| 8 | Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease Hit paper breakdown → | 2017 | 491 |
| 9 | Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study Hit paper breakdown → | 2010 | 436 |
| 10 | Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. Hit paper breakdown → | 1981 | 421 |
| 11 | Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial Hit paper breakdown → | 2017 | 400 |
| 12 | 2009 | 334 | |
| 13 | 2011 | 302 | |
| 14 | 2009 | 299 | |
| 15 | 2010 | 259 | |
| 16 | 2007 | 247 | |
| 17 | 2012 | 196 | |
| 18 | 2020 | 194 | |
| 19 | 2018 | 171 | |
| 20 | 2012 | 150 |
About Basil S. Lewis
Basil S. Lewis is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Epidemiology, having authored 278 papers that have together received 28.0k indexed citations. Recurring topics across this work include Cardiac Imaging and Diagnostics (59 papers), Cardiovascular Function and Risk Factors (47 papers), Atrial Fibrillation Management and Outcomes (37 papers), Antiplatelet Therapy and Cardiovascular Diseases (36 papers), Coronary Interventions and Diagnostics (36 papers), Heart Failure Treatment and Management (33 papers), Acute Myocardial Infarction Research (33 papers) and Cardiac Arrhythmias and Treatments (27 papers). The work is most often cited by research in Internal Medicine (6.9k citations), Cardiology and Cardiovascular Medicine (20.1k citations), Surgery (8.6k citations), Endocrinology, Diabetes and Metabolism (2.9k citations) and Radiology, Nuclear Medicine and Imaging (2.5k citations). Basil S. Lewis has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Salim Yusuf, Michael D. Ezekowitz, Harald Darius, Robert P. Giugliano, Lars Wallentin, Denis Xavier, Campbell Joyner, Rafael Díaz, Marco Alings and Hans‐Christoph Diener. Their work appears in journals such as The American Journal of Cardiology, American Heart Journal, Cardiology, Circulation and European Heart Journal - Cardiovascular Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.